# VTA-forebrain connectivity moderates adaptive behavior

**Authors:** Sadia Islam Sinza, Kwon Choi, Ignitius Ezekiel Lim, Madison Ashley Williams, Olalekan Michael Ogundele

PMC · DOI: 10.1007/s00429-026-03071-2 · Brain Structure & Function · 2026-02-03

## TL;DR

This paper explores how brain connections involving the VTA and hippocampus help with adaptive behaviors and decision-making.

## Contribution

The paper reviews the functional continuum between VTA-hippocampus and VTA-PFC circuits in adaptive behavior.

## Key findings

- VTA-hippocampus and VTA-PFC circuits are involved in adaptive behavior and decision-making.
- These circuits are linked to psychological and neurodevelopmental disorders.
- The GO-STOP framework explains coordinated brain activity for adaptive behaviors.

## Abstract

Neural representation of the environment is pertinent for adaptive behaviors. Such neural maps are processed in the hippocampus and contain information about spatial locations, novelties, context, and cues for context discrimination. In conjunction with other subcortical structures, a key function of the hippocampus is to compare newly detected novelties derived from the environment with previously stored cortical memories. These neural events underscore the role of the hippocampus as a “comparator” and “hub” for sorting novelties to determine priority and weight assignments for long-term cortical storage. To propagate these cognitive processes, mesocorticolimbic ventral tegmental area (VTA) inputs to the hippocampus and prefrontal cortex (PFC) compute detected novelties to derive frameworks for context discrimination, valence designation, and experience-based learning. Additionally, reciprocal connections between the VTA-hippocampus and VTA-PFC circuits are engaged for guided decisions and expression of adaptive behaviors. The significance of the functionally linked VTA-hippocampus and VTA-PFC axis in learning and guided decision-making has been generally described within the GO-STOP framework, which involves the coordinated activation or inhibition of ensembles in the prelimbic (PrL) and infralimbic (IL) cortices, among others. Although the GO-STOP hypothesis has been excellently described in recent works, this review evaluates the functional continuum between the VTA-hippocampus loop and VTA regulation of cortical-linked executive cognitive processes which underscore the expression of adaptive behaviors, with associated implications in psychological and neurodevelopmental disorders.

## Full-text entities

- **Genes:** ANKS1B (ankyrin repeat and sterile alpha motif domain containing 1B) [NCBI Gene 56899] {aka AIDA, AIDA-1, ANKS2, EB-1, EB1, cajalin-2}, CA3 (carbonic anhydrase 3) [NCBI Gene 761] {aka CAIII, Car3}, CRH (corticotropin releasing hormone) [NCBI Gene 1392] {aka CRF, CRH1}, Prl (prolactin) [NCBI Gene 24683] {aka Gha1, PRLB, PRLSD1, Prl1a1, Prol, RATPRLSD1}, NRG1 (neuregulin 1) [NCBI Gene 3084] {aka ARIA, GGF, GGF2, HGL, HRG, HRG1}, CALB1 (calbindin 1) [NCBI Gene 793] {aka CALB, D-28K}, SST (somatostatin) [NCBI Gene 6750] {aka SMST, SST1}, NTS (neurotensin) [NCBI Gene 4922] {aka NMN-125, NN, NT, NT/N, NTS1}, BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, CCK (cholecystokinin) [NCBI Gene 885], CA1 (carbonic anhydrase 1) [NCBI Gene 759] {aka CA-I, CAB, Car1, HEL-S-11}, CA2 (carbonic anhydrase 2) [NCBI Gene 760] {aka CA-II, CAC, CAII, Car2, HEL-76, HEL-S-282}, PVALB (parvalbumin) [NCBI Gene 5816] {aka D22S749}, DRD2 (dopamine receptor D2) [NCBI Gene 1813] {aka D2DR, D2R}, NRXN1 (neurexin 1) [NCBI Gene 9378] {aka Hs.22998, PTHSL2, SCZD17}
- **Diseases:** neurodevelopmental disorders (MESH:D002658), ASD (MESH:D000067877), attention deficit disorders (MESH:D001289), hyperactivity (MESH:D006948), addiction (MESH:D019966), degeneration (MESH:D009410), neurological and psychiatric disorders (MESH:D001523), anterograde and partial retrograde amnesias (MESH:D020324), PTSD (MESH:D013313), Down syndrome (MESH:D004314), Cholinergic (MESH:C535672), schizophrenia (MESH:D012559), 22q11 deletion (MESH:D058165), memory decline (MESH:D060825), autism (MESH:D001321), mood disorders (MESH:D019964), Parkinson's disease (MESH:D010300), anxiety (MESH:D001007), hippocampal dysfunction (MESH:D001927), amnesias (MESH:D000647), behavioral deficits (MESH:D019958), fear-learning impairments (MESH:D007859), focal epilepsy (MESH:D004828), OCD (MESH:D009771), depression (MESH:D003866), Alzheimer's (MESH:D000544), disorders (MESH:D009358), memory deficits (MESH:D008569), psychosis (MESH:D011618), impulsivity (MESH:D007174)
- **Chemicals:** L-DOPA (MESH:D007980), serotonergic (-), DA (MESH:D004298), glutamate (MESH:D018698), NE (MESH:D009638), GABA (MESH:D005680), amisulpride (MESH:D000077582)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12868095/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12868095/full.md

---
Source: https://tomesphere.com/paper/PMC12868095